HealthQuill asundexian
Swiss biotechnology company, Basilea Pharmaceutica’s last stage trials of ceftobiprole to treat bacterial bloodstream infections have shown favourable outcomes, according to a statement.
Drugs Medical Pharma

Bayer aborts late-stage trial of anticoagulant drug due to inefficacy

HQ Team November 20, 2023: Bayer, the pharmaceutical giant, has decided to halt a large late-stage trial for its experimental anticoagulant drug, asundexian..

Read More
X